207 related articles for article (PubMed ID: 32488137)
21. The Importance of Systemic Inflammation Markers in the Survival of Patients with Complicated Colorectal Cancer, Operated in Emergency.
Constantin GB; Firescu D; Voicu D; Ștefănescu B; Serban RMC; Panaitescu E; Bîrlă R; Constantinoiu S
Chirurgia (Bucur); 2020; 115(1):39-49. PubMed ID: 32155398
[No Abstract] [Full Text] [Related]
22. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer.
Hou Y; Li X; Yang Y; Shi H; Wang S; Gao M
Front Immunol; 2023; 14():1274431. PubMed ID: 38022654
[TBL] [Abstract][Full Text] [Related]
23. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.
Väyrynen JP; Väyrynen SA; Sirniö P; Minkkinen I; Klintrup K; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
J Transl Med; 2019 Jun; 17(1):199. PubMed ID: 31196200
[TBL] [Abstract][Full Text] [Related]
24. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
[TBL] [Abstract][Full Text] [Related]
25. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
[TBL] [Abstract][Full Text] [Related]
27. Association of nutritional risk and systemic inflammation with survival in patients with colorectal cancer who underwent curative surgery.
Nakamura Y; Imada A; Fukugaki A; Kanto S; Yamaura T; Kinjo Y; Kuroda N
Clin Nutr ESPEN; 2022 Jun; 49():417-424. PubMed ID: 35623847
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic value of preoperative inflammatory markers in patients with glioma: a multicenter cohort study.
Zheng SH; Huang JL; Chen M; Wang BL; Ou QS; Huang SY
J Neurosurg; 2018 Sep; 129(3):583-592. PubMed ID: 29099300
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival After TAS-102 Treatment of Patients With Metastatic Colorectal Cancer.
Matsuda A; Yamada T; Matsumoto S; Sakurazawa N; Kawano Y; Shinozuka E; Sekiguchi K; Suzuki H; Yoshida H
Anticancer Res; 2019 Aug; 39(8):4343-4350. PubMed ID: 31366528
[TBL] [Abstract][Full Text] [Related]
30. Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients.
Yamamoto T; Kawada K; Obama K
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360768
[TBL] [Abstract][Full Text] [Related]
31. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
32. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios.
Zager Y; Hoffman A; Dreznik Y; Jacoby H; Cordoba M; Horesh N; Nevler A; Gutman M; Berger Y
Surg Oncol; 2020 Dec; 35():321-327. PubMed ID: 32977104
[TBL] [Abstract][Full Text] [Related]
34. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?
Rossi S; Basso M; Strippoli A; Schinzari G; D'Argento E; Larocca M; Cassano A; Barone C
Clin Colorectal Cancer; 2017 Dec; 16(4):264-274. PubMed ID: 28412137
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment Nutrition-Inflammation Biomarkers Correlated with Differential Cytokine Profiles in Taiwanese Patients with Colorectal Cancer.
Yu YL; Tseng WK; Fan CW; Chang PH; Kuo HC; Pan YP; Yeh KY
Nutr Cancer; 2022; 74(5):1614-1624. PubMed ID: 34323132
[TBL] [Abstract][Full Text] [Related]
36. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
Chen L; Zeng H; Du Z; Zhao Y; Ma X
Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392
[TBL] [Abstract][Full Text] [Related]
37. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract][Full Text] [Related]
38. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
[TBL] [Abstract][Full Text] [Related]
39. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.
Watanabe J; Otani S; Sakamoto T; Arai Y; Hanaki T; Amisaki M; Tokuyasu N; Honjo S; Ikeguchi M
Surg Today; 2016 Nov; 46(11):1258-67. PubMed ID: 26869184
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapy.
Lin GN; Liu PP; Liu DY; Peng JW; Xiao JJ; Xia ZJ
Chin J Cancer; 2016 Jan; 35():5. PubMed ID: 26740116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]